News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 12526
- Sources here
- 20
- Companies here
- 33
Active search
12526 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?
Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as …
Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell
Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …
Responsive Playbooks and the ETON Inflection
This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …
Solstice Advanced Materials, Inc. (SOLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (NASDAQ: SOLS) following a significant stock price drop after its announcement to acquire Element Solutions for $14.5 billion. Despite the CEO's positive outlook on the acquisition, …
Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope
Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …
Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook
Eton Pharmaceuticals (ETON) saw its stock rise 32.0% after reporting a significant Q2 2026 earnings turnaround, with revenue surging to US$37.59 million and net income reaching US$11.58 million. The company also raised its full-year 2026 revenue guidance to at least US$145 million and expanded …
Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV
This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …
HII’s Newport News Shipbuilding Completes Successful Acceptance Sea Trials of John F. Kennedy (CVN 79)
HII NEWPORT NEWS, Va., Aug. 15, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Newport News Shipbuilding (NNS) division has successfully completed acceptance sea trials of John F. Kennedy (CVN 79), the second Gerald R. Ford-class nuclear-powered aircraft carrier. Kennedy returned …
Is General Mills (GIS) Reasonable for Value Investors Today?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. General Mills stock has had a weak run over the past few years, while current valuation checks suggest the shares are neither a clear bargain nor obviously …
Sharemaestro market context Price below Trend Line 52 weeks -32.3% · Next-week setup negative 28.5%Huntington Ingalls CEO Kastner sells $4.25m in HII stock
Christopher D. Kastner, CEO of Huntington Ingalls Industries (HII), sold 13,070 shares of the company's common stock for approximately $4.25 million on August 10, 2026, as part of a Rule 10b5-1 trading plan. Despite the sale, HII is considered undervalued, and the company recently …
Huntington Ingalls director Victoria Harker sells $240,878 in stock
Victoria D. Harker, a director at Huntington Ingalls Industries (NASDAQ:HII), recently sold 723 shares of common stock for a total of $240,878. This transaction occurred on August 7, 2026, at a price of $333.165 per share. The sale comes amidst positive company news, including …
Host Hotels (HST) Just Raised Its Outlook. Can Luxury Travel Keep Delivering?
Host Hotels & Resorts (NASDAQ:HST) held its second-quarter earnings call on August 6, and the numbers gave management enough confidence to raise full-year guidance by more than expected. Comparable hotel RevPAR climbed 7% to $251.53 in the quarter, and CEO James Risoleo pointed to …
Former Wells Fargo VP files $1.2M suit alleging age, race and LGBTQ discrimination
A former Wells Fargo executive, Robert Propst, has filed a $1.2 million lawsuit against the bank, alleging age, disability, and racial discrimination, as well as retaliation. Propst, 63, claims he was forcibly discharged in August 2023 after nearly 39 years with the company, facing …
General Mills (GIS), The Latest News Raises A Bigger Question
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Why a proposed charter change matters for General Mills stock General Mills (GIS) plans to ask shareholders on 29 September 2026 to approve …
Sharemaestro market context Price below Trend Line 52 weeks -32.3% · Next-week setup negative 28.5%Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Eton Pharmaceuticals (NASDAQ: ETON) saw its shares rise significantly in pre-market trading after reporting stronger-than-expected second-quarter financial results and providing an optimistic revenue guidance for FY26. The company exceeded analyst consensus estimates for both earnings per share and sales. The article also lists other …
ETFs Investing in Regeneron Pharmaceuticals, Inc. Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that invest in Regeneron Pharmaceuticals, Inc. (RGO) stocks. The list, sorted by market value, details each fund's symbol, market value, weight of RGO stock, issuer, management style, focus, expense ratio, assets under management …
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
This article compiles the latest analyst ratings and price target adjustments for ten different companies, including Applied Industrial Technologies, Eton Pharmaceuticals, Pelagos Insurance Capital, Braze, Veritone, Powell Industries, Applied Materials, Yeti Holdings, Workday, and Intuitive Machines. Analysts from firms like Mizuho, HC Wainwright & …
Nexmetals Mining Corp. Warrant 2025-17.11.2027 on Nexmetals mng
This page provides financial information for Nexmetals Mining Corp. Warrant 2025-17.11.2027 (TSXV:NEXM.WT), focusing on its enterprise value to revenue forward. It indicates that the market was closed with no trades recorded at the time of publication. The data is sourced from ICE Data Services …
SpaceX to launch Globalstar mission from Florida's Space Coast
SpaceX is set to launch the Globalstar 2-R Launch 1 mission from Cape Canaveral Space Force Station on Saturday night. The Falcon 9 rocket's first stage booster will be on its 14th flight and is expected to land back at Cape Canaveral. A backup …
TMC The Metals (TMC) Has Investors Watching, What Is Behind The Fresh Attention?
TMC The Metals (TMC) is gaining investor attention due to progress on U.S. seabed mining permits and advancements in its offshore collection system. Despite a recent 7-day share price return of 7.04%, the year-to-date performance shows a decline of 34.96%. The company's fair value …
ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold
ANI Pharmaceuticals (ANIP) is currently in focus after reporting its Q2 and H1 2026 results and reaffirming its full-year net revenue outlook of $1,080 million to $1,140 million. Despite recent strong earnings, the stock has seen a short-term decline, though it shows significant long-term …
Black Stone Minerals (BSM) Could Be 10% Below Fair Value After Revenue Beat
Black Stone Minerals (BSM) is considered undervalued after exceeding second-quarter revenue expectations due to steady oil volumes and favorable pricing, resulting in a higher cash distribution. Analysts suggest a fair value of $16, indicating a 10.1% undervaluation from its current $14.38 share price, largely …